FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 113 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 469.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,473,000 | -33.2% | 275,753 | -33.2% | 0.00% | -100.0% |
| Q4 2020 | $2,205,000 | +186.4% | 412,982 | +152.1% | 0.00% | – |
| Q3 2020 | $770,000 | -5.4% | 163,846 | +22.8% | 0.00% | – |
| Q2 2020 | $814,000 | +125.5% | 133,437 | -16.0% | 0.00% | – |
| Q1 2020 | $361,000 | -28.2% | 158,805 | +44.8% | 0.00% | – |
| Q4 2019 | $503,000 | -78.9% | 109,688 | -82.2% | 0.00% | -100.0% |
| Q3 2019 | $2,383,000 | -23.8% | 614,947 | +18.5% | 0.00% | 0.0% |
| Q2 2019 | $3,128,000 | +285.7% | 518,760 | +3107.2% | 0.00% | -75.0% |
| Q4 2016 | $811,000 | -5.0% | 16,175 | -0.6% | 0.00% | -20.0% |
| Q3 2016 | $854,000 | +28.4% | 16,272 | +1.2% | 0.01% | +25.0% |
| Q2 2016 | $665,000 | +10.5% | 16,072 | +8.6% | 0.00% | +33.3% |
| Q1 2016 | $602,000 | – | 14,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 601,000 | $24,587,000 | 1.39% |
| HealthCor Management, L.P. | 1,010,930 | $41,357,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 86,500 | $3,535,000 | 1.38% |
| PURA VIDA INVESTMENTS, LLC | 75,000 | $3,068,000 | 0.90% |
| BB BIOTECH AG | 777,500 | $31,808,000 | 0.88% |
| AWM Investment Company, Inc. | 100,000 | $4,091,000 | 0.71% |
| Granite Point Capital Management, L.P. | 50,000 | $2,046,000 | 0.43% |
| Rock Springs Capital Management LP | 217,700 | $8,906,000 | 0.41% |
| Crestline Management, LP | 50,919 | $2,083,000 | 0.29% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,432,700 | $99,522,000 | 0.24% |